QUEBEC, Aug. 3 /PRNewswire-FirstCall/ -- AEterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS) announced that its Second Quarter 2006 conference call and webcast have been scheduled for Friday, August 11, 2006, at 11:00 a.m. ET. The conference call will follow the press release of AEterna Zentaris' 2006 second quarter financial and operating results issued earlier on the same day. Participants may access the live webcast via the Company's website at http://www.aeternazentaris.com/ in the "investors" section, or by telephone using the following number: 800-257-3401. A replay of the webcast will also be available on the website for a period of 30 days. About AEterna Zentaris Inc. AEterna Zentaris Inc. is a growing global biopharmaceutical company engaged in the discovery, development and marketing of therapies for cancer and endocrine disorders. AEterna Zentaris also owns 48.26% of the equity of Atrium Biotechnologies Inc. (TSX: ATB) and 64.69% of its voting rights. Atrium is a developer, manufacturer and marketer of science-based products for the cosmetics, pharmaceutical, chemical and nutritional industries. News releases and additional information are available at http://www.aeternazentaris.com/. DATASOURCE: AETERNA ZENTARIS INC. (FORMERLY/ANCIENNEMENT - LES LABORATOIRES AETERNA LABORATORIES INC.) CONTACT: Media Relations: Paul Burroughs, (418) 652-8525 ext. 406, ; Investor Relations: Jenene Thomas, (418) 655-6420 or (908) 996-3154,

Copyright